Cowen strengthens equity capital markets team with the appointment of brian hagerty as managing director, biotechnology

New york , feb. 28, 2022 (globe newswire) -- cowen inc. (nasdaq:cown) (“cowen” or the “company”) today announced that brian hagerty has joined the company's equity capital markets team as a managing director focused on biotechnology. mr. hagerty will be based in new york and report to grant miller, managing director and head of capital markets, and will work closely with cowen's senior healthcare capital markets team of managing directors, mariel healy, and michael campbell.
COWN Ratings Summary
COWN Quant Ranking